BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10779761)

  • 1. A VH11V kappa 9 B cell antigen receptor drives generation of CD5+ B cells both in vivo and in vitro.
    Chumley MJ; Dal Porto JM; Kawaguchi S; Cambier JC; Nemazee D; Hardy RR
    J Immunol; 2000 May; 164(9):4586-93. PubMed ID: 10779761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa editing rescues autoreactive B cells destined for deletion in mice transgenic for a dual specific anti-laminin Ig.
    Brady GF; Congdon KL; Clark AG; Sackey FN; Rudolph EH; Radic MZ; Foster MH
    J Immunol; 2004 May; 172(9):5313-21. PubMed ID: 15100270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Truncation of the mu heavy chain alters BCR signalling and allows recruitment of CD5+ B cells.
    Zou X; Ayling C; Xian J; Piper TA; Barker PJ; Brüggemann M
    Int Immunol; 2001 Dec; 13(12):1489-99. PubMed ID: 11717190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive surface B cell antigen receptor down-regulation accompanies efficient development of antinuclear antigen B cells to mature, follicular phenotype.
    Heltemes-Harris L; Liu X; Manser T
    J Immunol; 2004 Jan; 172(2):823-33. PubMed ID: 14707052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional mu heavy chains.
    Kline GH; Hartwell L; Beck-Engeser GB; Keyna U; Zaharevitz S; Klinman NR; Jäck HM
    J Immunol; 1998 Aug; 161(4):1608-18. PubMed ID: 9712022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and selection of edited B cells in B6.56R mice.
    Sekiguchi DR; Yunk L; Gary D; Charan D; Srivastava B; Allman D; Weigert MG; Prak ET
    J Immunol; 2006 Jun; 176(11):6879-87. PubMed ID: 16709848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a ligand-mediated positive selection signal in differentiation to a mature B cell.
    Wang H; Clarke SH
    J Immunol; 2003 Dec; 171(12):6381-8. PubMed ID: 14662836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic and isotypic light chain inclusion in peripheral B cells from anti-DNA antibody transgenic C57BL/6 and BALB/c mice.
    Witsch EJ; Bettelheim E
    J Immunol; 2008 Mar; 180(6):3708-18. PubMed ID: 18322176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of B-1 B cells with follicular dendritic cells in spleen.
    Wen L; Shinton SA; Hardy RR; Hayakawa K
    J Immunol; 2005 Jun; 174(11):6918-26. PubMed ID: 15905534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic expression of a human polyreactive Ig expressed in chronic lymphocytic leukemia generates memory-type B cells that respond to nonspecific immune activation.
    Widhopf GF; Brinson DC; Kipps TJ; Tighe H
    J Immunol; 2004 Feb; 172(4):2092-9. PubMed ID: 14764674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cell progenitors are arrested in maturation but have intact VDJ recombination in the absence of Ig-alpha and Ig-beta.
    Pelanda R; Braun U; Hobeika E; Nussenzweig MC; Reth M
    J Immunol; 2002 Jul; 169(2):865-72. PubMed ID: 12097390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors.
    Kenny JJ; Rezanka LJ; Lustig A; Fischer RT; Yoder J; Marshall S; Longo DL
    J Immunol; 2000 Apr; 164(8):4111-9. PubMed ID: 10754305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ig light chain receptor editing in anergic B cells.
    Tze LE; Baness EA; Hippen KL; Behrens TW
    J Immunol; 2000 Dec; 165(12):6796-802. PubMed ID: 11120801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of myelin oligodendrocyte glycoprotein autoreactive transgenic B lymphocytes: receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein.
    Litzenburger T; Blüthmann H; Morales P; Pham-Dinh D; Dautigny A; Wekerle H; Iglesias A
    J Immunol; 2000 Nov; 165(9):5360-6. PubMed ID: 11046072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic human lambda 5 rescues the murine lambda 5 nullizygous phenotype.
    Donohoe ME; Beck-Engeser GB; Lonberg N; Karasuyama H; Riley RL; Jäck HM; Blomberg BB
    J Immunol; 2000 May; 164(10):5269-76. PubMed ID: 10799888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance through indifference: autoreactive B cells to the nuclear antigen La show no evidence of tolerance in a transgenic model.
    Aplin BD; Keech CL; de Kauwe AL; Gordon TP; Cavill D; McCluskey J
    J Immunol; 2003 Dec; 171(11):5890-900. PubMed ID: 14634099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple levels of selection responsive to immunoglobulin light chain and heavy chain structures impede the development of Dmu-expressing B cells.
    Guloglu FB; Smith BP; Roman CA
    J Immunol; 2008 Sep; 181(6):4098-106. PubMed ID: 18768866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene dose-dependent maturation and receptor editing of B cells expressing immunoglobulin (Ig)G1 or IgM/IgG1 tail antigen receptors.
    Pogue SL; Goodnow CC
    J Exp Med; 2000 Mar; 191(6):1031-44. PubMed ID: 10727464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells.
    Bikah G; Carey J; Ciallella JR; Tarakhovsky A; Bondada S
    Science; 1996 Dec; 274(5294):1906-9. PubMed ID: 8943203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging-dependent exclusion of antigen-inexperienced cells from the peripheral B cell repertoire.
    Johnson SA; Rozzo SJ; Cambier JC
    J Immunol; 2002 May; 168(10):5014-23. PubMed ID: 11994453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.